Twist Bioscience Expands North American Presence With Office in San Diego, California

SAN FRANCISCO & CARLSBAD, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its North American operations with a new office in the San Diego area. The office will support sales and marketing as well as other corporate administrative functions and will be the headquarters for customer support for the company’s recently-launched solutions to enhance next-generation sequencing.

“Our expansion into Carlsbad allows us to tap into the experienced talent pool in this community as we augment our capabilities and increase our product offerings to further serve the evolving needs of our customers,” said Emily M. Leproust, Ph.D., CEO of Twist Bioscience. “We believe the San Diego community will play an integral role in our growth. We continue to hit major corporate milestones, including the launch of our e-commerce platform, which allows companies and institutions to design, validate, and place on-demand orders of customized DNA online, and the significant expansion of our product portfolio to include exome and custom target enrichment solutions. In addition, we continue to ship industry-leading volumes of synthetic DNA, with over 150,000 genes shipped in the last 12 months.”

Twist Bioscience expects to hire employees in the San Diego area to fill the 2,500 square-foot office space. Twist Bioscience is headquartered in San Francisco, California with a second site in South San Francisco and international offices in Tel Aviv, Israel.

About Twist Bioscience Corporation

At Twist Bioscience Corporation, we work in service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals, academic research and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. We believe that the faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts.

Our innovative silicon-based DNA synthesis platform provides precision at a scale that we believe is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.

Contacts

Investor Contact:
Argot Partners
Maeve Conneighton, 212-600-1902
maeve@argotpartners.com
or
Media Contact:
Angela Bitting, 925-202-6211
media@twistbioscience.com

 
 

Source: Twist Bioscience Corporation

Back to news